학술논문
RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study
Document Type
Abstract
Author
Carlo-Stella, Carmelo; Mazza, Rita ; Manier, Salomon; Facon, Thierry ; Yoon, Sung-Soo; Koh, Youngil ; Harrison, Simon J; Er, Jeremy ; Pinto, Antonio ; Volzone, Francesco ; Perrone, Giulia ; Corradini, Paolo; Cazaubiel, Titouan ; Hulin, Cyrille ; Touzeau, Cyrille ; Moreau, Philippe ; Ocio, Enrique M.; Montes Gaisan, Carmen Maria ; Popat, Rakesh ; Leong, Sarah ; Offner, Fritz; Rodriguez Otero, Paula ; Alfonso-Pierola, Ana ; Bröske, Ann-Marie E ; Dekhtiarenko, Iryna ; Helms, Hans-Joachim ; Belli, Sara ; Rossmann, Eva ; Fauti, Tanja ; Eckmann, Jan ; Moore, Tom ; Schneider, Meike ; Jacob, Wolfgang ; Weisser, Martin ; Hutchings, Martin ; Riley, Caroline Hasselbalch
Source
In Blood 15 November 2022 140 Supplement 1:397-399
Subject
Language
ISSN
0006-4971